Assembly Biosciences (ASMB) closed at $19.84 on October 23, 2026, down 2.2% from the previous close, on volume of 203,807 shares (30-day average 314,638).
Data as of October 23, 2026.
23-Oct-2026
Globe Newswire (Mon, 5-Oct 10:00 AM ET)
Globe Newswire (Thu, 10-Sep 4:15 PM ET)
Globe Newswire (Tue, 8-Sep 4:00 PM ET)
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
Globe Newswire (Thu, 13-Aug 4:00 PM ET)
Market Chameleon (Fri, 20-Mar 5:59 AM ET)
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Assembly Biosciences trades on the NASDAQ stock market under the symbol ASMB.
As of October 23, 2026, ASMB stock price declined to $19.84 with 203,807 million shares trading.
ASMB has a beta of 1.19, meaning it tends to be more sensitive to market movements. ASMB has a correlation of 0.07 to the broad based SPY ETF.
ASMB has a market cap of $403.95 million. This is considered a Small Cap stock.
Last quarter Assembly Biosciences reported $13 million in Revenue and -$.20 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.36.
In the last 3 years, ASMB traded as high as $39.71 and as low as $7.69.
The top ETF exchange traded funds that ASMB belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWN.
ASMB has underperformed the market in the last year with a price return of -27.8% while the SPY ETF gained +14.3%. ASMB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.3% and -15.7%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
ASMB support price is $19.55 and resistance is $21.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASMB shares will trade within this expected range on the day.
